Medical device licence · 73715 · Class 2
ETEST ANTIMICROBIAL SUSCEPTIBILITY TESTING
Yes: licensed in Canada
Licence status Issued (active); first licensed April 4, 2007. It is in Health Canada’s list of active licences.
- Licence number
- 73715
- Licence holder
- Biomerieux SaRockland, MA, United States
- Risk class
- Class II (low to moderate risk)
- Licence type
- Device Family
- First licensed
- April 4, 2007
- Devices covered
- 95
Devices on this licence
By name, as listed. The official record lists model numbers and identifiers.
- ETEST AMOXICILLIN (AC)
- ETEST AMOXICILLIN/CLAVULANIC ACID
- ETEST AMPICILLIN
- ETEST ANTIMICROBIAL SUSCEPTIBILITY MUPIROCIN
- ETEST ANTIMICROBIAL SUSCEPTIBILITY TESTING - AMIKACIN
- ETEST ANTIMICROBIAL SUSCEPTIBILITY TESTING - AMOXICILLIN
- ETEST ANTIMICROBIAL SUSCEPTIBILITY TESTING - AMOXICILLIN/CLAVULANIC ACID
- ETEST ANTIMICROBIAL SUSCEPTIBILITY TESTING - AMPICILLIN
- ETEST ANTIMICROBIAL SUSCEPTIBILITY TESTING - AMPICILLIN/SULBACTAM
- ETEST ANTIMICROBIAL SUSCEPTIBILITY TESTING - AZITHROMYCIN
- ETEST ANTIMICROBIAL SUSCEPTIBILITY TESTING - AZTREONAM
- ETEST ANTIMICROBIAL SUSCEPTIBILITY TESTING - BENZYLPENICILLIN
- ETEST ANTIMICROBIAL SUSCEPTIBILITY TESTING - CEFEPIME
- ETEST ANTIMICROBIAL SUSCEPTIBILITY TESTING - CEFOTAXIME
- ETEST ANTIMICROBIAL SUSCEPTIBILITY TESTING - CEFPODOXIME
- ETEST ANTIMICROBIAL SUSCEPTIBILITY TESTING - CEFTAROLINE
- ETEST ANTIMICROBIAL SUSCEPTIBILITY TESTING - CEFTAZIDIME
- ETEST ANTIMICROBIAL SUSCEPTIBILITY TESTING - CEFTRIAXONE
- ETEST ANTIMICROBIAL SUSCEPTIBILITY TESTING - CEFUROXIME
- ETEST ANTIMICROBIAL SUSCEPTIBILITY TESTING - CIPROFLOXACIN
- ETEST ANTIMICROBIAL SUSCEPTIBILITY TESTING - CLINDAMYCIN
- ETEST ANTIMICROBIAL SUSCEPTIBILITY TESTING - COLISTIN
- ETEST ANTIMICROBIAL SUSCEPTIBILITY TESTING - DAPTOMYCIN
- ETEST ANTIMICROBIAL SUSCEPTIBILITY TESTING - DOXYCYCLINE
- ETEST ANTIMICROBIAL SUSCEPTIBILITY TESTING - ERYTHROMYCIN
- ETEST ANTIMICROBIAL SUSCEPTIBILITY TESTING - GENTAMICIN
- ETEST ANTIMICROBIAL SUSCEPTIBILITY TESTING - IMIPENEM
- ETEST ANTIMICROBIAL SUSCEPTIBILITY TESTING - KANAMYCIN
- ETEST ANTIMICROBIAL SUSCEPTIBILITY TESTING - LEVOFLOXACIN
- ETEST ANTIMICROBIAL SUSCEPTIBILITY TESTING - LINEZOLID
- ETEST ANTIMICROBIAL SUSCEPTIBILITY TESTING - MEROPENEM
- ETEST ANTIMICROBIAL SUSCEPTIBILITY TESTING - METRONIDAZOLE
- ETEST ANTIMICROBIAL SUSCEPTIBILITY TESTING - NALIDIXIC ACID
- ETEST ANTIMICROBIAL SUSCEPTIBILITY TESTING - NETILMICIN
- ETEST ANTIMICROBIAL SUSCEPTIBILITY TESTING - NITROFURANTOIN
- ETEST ANTIMICROBIAL SUSCEPTIBILITY TESTING - NORFLOXACIN
- ETEST ANTIMICROBIAL SUSCEPTIBILITY TESTING - OXACILLIN
- ETEST ANTIMICROBIAL SUSCEPTIBILITY TESTING - PIPERACILLIN
- ETEST ANTIMICROBIAL SUSCEPTIBILITY TESTING - POLYMYXIN B
- ETEST ANTIMICROBIAL SUSCEPTIBILITY TESTING - SPECTINOMYCIN
- ETEST ANTIMICROBIAL SUSCEPTIBILITY TESTING - STREPTOMYCIN
- ETEST ANTIMICROBIAL SUSCEPTIBILITY TESTING - TEICOPLANIN
- ETEST ANTIMICROBIAL SUSCEPTIBILITY TESTING - TEMOCILLIN
- ETEST ANTIMICROBIAL SUSCEPTIBILITY TESTING - TETRACYCLINE
- ETEST ANTIMICROBIAL SUSCEPTIBILITY TESTING - TIGECYCLINE
- ETEST ANTIMICROBIAL SUSCEPTIBILITY TESTING - TOBRAMYCIN
- ETEST ANTIMICROBIAL SUSCEPTIBILITY TESTING - TRIMETHOPRIM
- ETEST ANTIMICROBIAL SUSCEPTIBILITY TESTING - TRIMETHOPRIM/SULFAMETHOXAZOLE
- ETEST ANTIMICROBIAL SUSCEPTIBILITY TESTING - VANCOMYCIN
- ETEST ANTIMICROBIAL SUSCEPTIBILITY TESTING- DORIPENEM
- ETEST AZITHROMYCIN
- ETEST AZTREONAM/ AVIBACTAM (AZA)
- ETEST BENZYLPENICILLIN (PG)
- ETEST CEFEPIME
- ETEST CEFIXIME IX 256
- ETEST CEFOXITIN (FX)
- ETEST CEFTAROLINE (CPT)
- ETEST CEFTAZIDIME (TZ)
- ETEST CEFTAZIDIME/AVIBACTAM (CZA 256)
- ETEST CEFTOLOZANE/TAZOBACTAM (C/T)
- ETEST CEFTRIAXONE (TX)
- ETEST CEPHALOTHIN CE 256
- ETEST CHLORAMPHENICOL
- ETEST CIPROFLOXACIN (CI)
- ETEST CLARITHROMYCIN CH 256
- ETEST CLINDAMYCIN
- ETEST DAPTOMYCIN (DPC)
- ETEST DOXYCYCLINE (DC)
- ETEST DOXYCYCLINE DC 256
- ETEST ERAVACYCLINE (ERV)
- ETEST ERTAPENEM
- ETEST ERYTHROMYCIN (EM)
- ETEST FOSFOMYCIN (FO)
- ETEST GENTAMICIN (GM)
- ETEST IMIPENEM/RELEBACTAM (IPR)
- ETEST IMIPENEM/RELEBACTAM P. AERUGINOSA IRPA
- ETEST LEVOFLOXACIN (LE)
- ETEST LINEZOLID
- ETEST MEROPENEM (MP)
- ETEST MEROPENEM/VABORBACTA M (MEV)
- ETEST METRONIDAZOLE
- ETEST MINOCYCLINE MC 256
- ETEST MOXIFLOXACIN (MX)
- ETEST MUPIROCIN (MU)
- ETEST NITROFURANTOIN
- ETEST PIPERACILLIN/TAZOBACTAM (P/T)
- ETEST RIFAMPICIN (RI)
- ETEST RIFAMPICIN RI 32
- ETEST STREPTOMYCIN
- ETEST TEICOPLANIN
- ETEST TETRACYCLINE (TC)
- ETEST TIC/CLAV-CON2 TLC 256
- ETEST TIGECYCLINE (TGC)
- ETEST TRIMETHOPRIM/SULFAMETH OXAZOLE (TS)
- ETEST VANCOMYCIN (VA)
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “etest”. A notice may cover another product or only some lots: read it to see what it covers.
- ETEST Antimicrobial Susceptibility Testing - Polymyxin B (2017-01-23)February 6, 2018 · Medical devices · Medical devices · Type I
- ETEST Antimicrobial Susceptibility Testing - Teicoplanin (2017-12-14)January 12, 2018 · Medical devices · Medical devices · Type II
- Etest Antimicrobial Susceptibility Testing - OxacMay 16, 2017 · Medical devices · Type II
- Etest Antimicrobial Susceptibility Testing - ErtaApril 6, 2017 · Medical devices · Type II
- Etest Antimicrobial Susceptibility Testing - CEFUFebruary 14, 2017 · Medical devices · Type II
- Various ETEST Antimicorbial Susceptibility Tests (2016-12-28)January 25, 2017 · Medical devices · Medical devices · Type III
- ETEST Antimicrobial Susceptibility Testing - Ceftriaxone Txl32January 25, 2017 · Medical devices · Type II
- ETEST ANTIMICROBIAL SUSCEPTIBILITY TESTING - COLI (2016-07-26)August 19, 2016 · Medical devices · Medical devices · Type II
- ETEST ANTIMICROBIAL SUSCEPTIBILITY TESTING (2015-11-26)January 14, 2016 · Medical devices · Health products · Type II
- ETEST ANTIMICROBIAL SUSCEPTIBILITY TESTING - CEFO (2015-06-12)July 9, 2015 · Medical devices · Health products · Type I
- Etest Ertapenem Foam ETP 32 (2014-02-17)April 14, 2014 · Medical devices · Medical devices · Type III
Class I devices, the lowest-risk group, mostly need no device licence, so most are not in this list.